CCL20/CCR6 expression profile in pancreatic cancer

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Rubie, Claudia ^a   Frick, Vilma O ^a   Ghadjar, Pirus ^b   Wagner, Mathias ^a   Grimm, Henner ^a   Vicinus, Benjamin ^a   Justinger, Christoph ^a   Graeber, Stefan ^a   Schilling, Martin K ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; CCL20 PROTEIN, HUMAN; CCR6 PROTEIN, HUMAN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYSTADENOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS CARCINOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CANCER STAGING; GENETICS; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CHEMOKINE CCL20; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; RECEPTORS, CCR6; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77951971283     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-45     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statitstics 2007. CA Cancer J Clin 2007, 57:43-66. 10.3322/canjclin.57.1.43, 17237035.
2. Lillemoe KD, Yeo CJ, Cameron JL. Pancreatic cancer: state-of-the-art care. CA Cancer J Clin 2000, 50:241-268. 10.3322/canjclin.50.4.241, 10986966.
3. Conlon KC, Klimstra DS, Brennan MF. Longterm survival after curative resection for pancreatic ductal adenocarcinoma: clinicopathologic analysis for 5-years survivors. Ann Surg 1996, 223:272-279.
4. Korc M. Role of growth factors in pancreatic cancer. Surg Oncol Clin N Am 1998, 7:25-41.
5. Friess H, Kleeff J, Klockow N, Ebert M, Malfertheiner P, Büchler MW. Molekulare Veränderungen bei Pankreas- und periampullären Karzinomen. Chir Gastroenterol 1999, 15:150-157.
6. Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R. Cytokines in pancreatic cancer - correlation with phenotypic characteristics and prognosis. Cancer 2004, 101:2727-2736. 10.1002/cncr.20672, 15526319.
7. Matsuo Y, Sawai H, Funahashi H, Takahashi H, Sakamoto M, Yamamoto M, Okada Y, Hayakawa T, Manabe T. Enhanced angiogenesis due to inflammatory cytokines from pancreatic cancer cell lines and relation to metastatic potential. Pancreas 2004, 28:344-352. 10.1097/00006676-200404000-00025, 15084984.
8. Marchesi F, Monti P, Leone BE, Zerbi A, Vecchi A, Piemonti L, Mantovani A, Allavena P. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 2004, 64:8420-8427. 10.1158/0008-5472.CAN-04-1343, 15548713.
9. Matsuo Y, Ochi N, Sawai H, Yasuda A, Takahashi H, Funahashi H, Takeyama H, Tong Z, Guha S. CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer 2009, 124:853-861. 10.1002/ijc.24040, 2684108, 19035451.
10. Wente MN, Mayer C, Gaida MM, Michalski CW, Giese T, Bergmann F, Giese NA, Büchler MW, Friess H. CXCL14 expression and potential function in pancreatic cancer. Cancer Lett 2008, 259:209-217. 10.1016/j.canlet.2007.10.021, 18054154.
11. Wang Z, Ma Q, Liu Q, Yu H, Zhao L, Shen S, Yao J. Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway. Br J Cancer 2008, 99:1695-1703. 10.1038/sj.bjc.6604745, 2584946, 19002187.
12. Kulbe H, Levinson NR, Balkwill F, Wilson JL. The chemokine network in cancer--much more than directing cell movement. Int J Dev Biol 2004, 48:489-496. 10.1387/ijdb.041814hk, 15349823.
13. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004, 4:540-550. 10.1038/nrc1388, 15229479.
14. Kleeff J, Kusama T, Rossi DL, Ishiwata T, Maruyama H, Friess H, Büchler MW, Zlotnik A, Korc M. Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer 1999, 81:650-657. 10.1002/(SICI)1097-0215(19990517)81:4<650::AID-IJC23>3.0.CO;2-#, 10225458.
15. Kimsey TF, Campbell AS, Albo D, Wilson M, Wang TN. Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion. Cancer J 2004, 10:374-380. 10.1097/00130404-200411000-00007, 15701269.
16. Campbell AS, Albo D, Kimsey TF, White SL, Wang TN. Macrophage inflammatory protein-3alpha promotes pancreatic cancer cell invasion. J Surg Res 2005, 123:96-101. 10.1016/j.jss.2004.07.013, 15652956.
17. Caux C, Vanbervliet B, Massacrier C, Ait-Yahia S, Vaure C, Chemin K, Dieu-Nosjean And MC, Vicari A. Regulation of dendritic cell recruitment by chemokines. Transplantation 2002, 73:7-11. 10.1097/00007890-200201151-00005, 11792971.
18. Greaves DR, Wang W, Dairaghi DJ, Dieu MC, Saint-Vis B, Franz-Bacon K, Rossi D, Caux C, McClanahan T, Gordon S, Zlotnik A, Schall TJ. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med 1997, 186:837-844. 10.1084/jem.186.6.837, 2199049, 9294138.
19. Ghadjar P, Coupland SE, Na IK, Noutsias M, Letsch A, Stroux A, Bauer S, Buhr HJ, Thiel E, Scheibenbogen C, Keilholz U. Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J Clin Oncol 2006, 24:1910-1916. 10.1200/JCO.2005.04.1822, 16622267.
20. Rubie C, Frick VO, Wagner M, Rau B, Weber C, Kruse B, Kempf K, Tilton B, König J, Schilling M. Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma. Scand J Immunol 2006, 63:468-477. 10.1111/j.1365-3083.2006.001766.x, 16764701.
21. Abiko Y, Nishimura M, Kusano K, Nakashima K, Okumura K, Arakawa T, Takuma T, Mizoguchi I, Kaku T. Expression of MIP-3alpha/CCL20, a macrophage inflammatory protein in oral squamous cell carcinoma. Arch Oral Biol 2003, 48:171-175. 10.1016/S0003-9969(02)00167-X, 12642237.
22. Ghadjar P, Loddenkemper C, Coupland SE, Stroux A, Noutsias M, Thiel E, Christoph F, Miller K, Scheibenbogen C, Keilholz U. Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer. J Cancer Res Clin Oncol 2008, 134:1181-1189. 10.1007/s00432-008-0403-5, 18465142.
23. UICC TNM classification of malignant tumors. 1997, New York: Wiley-Liss, 5, UICC.
24. Bustin SA. Absolute quantification of mRNA using real time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000, 25:169-193. 10.1677/jme.0.0250169, 11013345.
25. Rubie C, Kempf K, Hans J, Su T, Tilton B, Georg T, Brittner B, Ludwig B, Schilling M. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues. Mol Cell Probe 2005, 19:101-109.
26. Schoonjans F, Zalata A, Depuydt CE, Comhaire FH. MedCalc: a new computer program for medical statistics. Comp Meth Pro Biomed 1995, 48:257-262.
27. Howes N, Neoptolemos JP. Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis. Gut 2002, 51:765-766. 10.1136/gut.51.6.765, 1773485, 12427771.
28. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andren-Sandberg A, Domellof L. Pancreatitis and the risk for pancreatic cancer. N Engl J Med 1993, 328:1433-1437. 10.1056/NEJM199305203282001, 8479461.
29. Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, Abbondanzo SJ, Niu XD, Chen SC, Manfra DJ, Wiekowski MT, Sullivan LM, Smith SR, Greenberg HB, Narula SK, Lipp M, Lira SA. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 2000, 12:495-503. 10.1016/S1074-7613(00)80201-0, 10843382.
30. Lukacs NW, Prosser DM, Wiekowski M, Lira SA, Cook DN. Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation. J Exp Med 2001, 194:551-555. 10.1084/jem.194.4.551, 2193496, 11514610.
31. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Aït-Yahia S, Brière F, Zlotnik A, Lebecque S, Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998, 188:373-386. 10.1084/jem.188.2.373, 2212459, 9670049.
32. Ekbom A, McLaughlin JK, Karlsson BM, Nyrén O, Gridley G, Adami HO, Fraumeni JF. Pancreatitis and pancreatic cancer: a population-based study. J Natl Cancer Inst 1994, 86:625-627. 10.1093/jnci/86.8.625, 8145277.
33. Karlson BM, Ekbom A, Josefsson S, McLaughlin JK, Fraumeni JF, Nyrén O. The risk of pancreatic cancer following pancreatitis: an association due to confounding?. Gastroenterology 1997, 113:587-592. 10.1053/gast.1997.v113.pm9247480, 9247480.
34. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007, 132:2208-2225. 10.1053/j.gastro.2007.03.050, 17498513.
35. Rubie C, Oliveira V, Kempf K, Wagner M, Tilton B, Rau B, Kruse B, Konig J, Schilling M. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumour Biol 2006, 27:166-174. 10.1159/000092777, 16641550.
36. Matsui T, Akahoshi T, Namai R, Hashimoto A, Kurihara Y, Rana M, Nishimura A, Endo H, Kitasato H, Kawai S, Takagishi K, Kondo H. Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis. Clin Exp Immunol 2001, 125:155-161. 10.1046/j.1365-2249.2001.01542.x, 1906097, 11472439.
37. Shimizu Y, Murata H, Kashii Y, Hirano K, Kunitani H, Higuchi K, Watanabe A. CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be involved in the amplification of local necroinflammatory response in the liver. Hepatology 2001, 34:311-319. 10.1053/jhep.2001.26631, 11481616.
38. Homey B, Dieu-Nosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E, Catron D, Buchanan ME, Müller A, deWaal Malefyt R, Deng G, Orozco R, Ruzicka T, Lehmann P, Lebecque S, Caux C, Zlotnik A. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 2000, 164:6621-6632.